Meeting
2023 ASCO Annual Meeting
A randomized phase III clinical trial of yoga for chemotherapy-induced peripheral neuropathy treatment.
Authors
Kirin Saint
Memorial Sloan Kettering Cancer Center, New York, NY
Kirin Saint , Katherine Han , Lauren Piulson , Christina Seluzicki , Iris Zhi , Ting Bao
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Symptoms and Survivorship
Track
Symptom Science and Palliative Care
Sub Track
Late and Long-Term Adverse Effects
Clinical Trial Registration Number
NCT05121558
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr TPS12143)
DOI
10.1200/JCO.2023.41.16_suppl.TPS12143
Abstract #
TPS12143
Poster Bd #
508a
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
A randomized phase III clinical trial of yoga for chemotherapy-induced peripheral neuropathy treatment.
First Author: Katherine Han
Poster
2022 ASCO Annual Meeting
A randomized phase III clinical trial of acupuncture for chemotherapy-induced peripheral neuropathy (CIPN) in cancer survivors.
First Author: Andee Dooley
Poster
2022 ASCO Annual Meeting
Impact of adverse health outcomes (AHOs) on self-reported physical and mental health in U.S. testicular cancer survivors (TCS).
First Author: Paul C. Dinh Jr.
Poster
2021 ASCO Annual Meeting
Quality of life, functioning, and symptoms in patients with previously treated locally advanced or metastatic urothelial carcinoma from EV-301: A randomized phase 3 trial of enfortumab vedotin versus chemotherapy.
First Author: Ronac Mamtani